Header

UZH-Logo

Maintenance Infos

Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis


Pfender, N; Saccardi, R; Martin, R (2013). Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis. Current Treatment Options in Neurology, 15(3):270-280.

Abstract

OPINION STATEMENT: Despite the development of several injectable or oral treatments for relapsing-remitting multiple sclerosis (RRMS), it remains difficult to treat patients with aggressive disease, and many of these continue to develop severe disability. During the last two decades autologous hematopoietic stem cell transplantation (aHSCT) has been explored with the goal to eliminate an aberrant immune system and then re-install a healthy and tolerant one from hematopoietic precursor cells that had been harvested from the patient prior to chemotherapy. Clinical studies have shown that aHSCT is able to completely halt disease activity in the majority of patients with aggressive RRMS. Research on the mechanisms of action supports that aHSCT indeed leads to renewal of a healthy immune system. Below we will summarize important aspects of aHSCT and mention the currently best-examined regimen.

Abstract

OPINION STATEMENT: Despite the development of several injectable or oral treatments for relapsing-remitting multiple sclerosis (RRMS), it remains difficult to treat patients with aggressive disease, and many of these continue to develop severe disability. During the last two decades autologous hematopoietic stem cell transplantation (aHSCT) has been explored with the goal to eliminate an aberrant immune system and then re-install a healthy and tolerant one from hematopoietic precursor cells that had been harvested from the patient prior to chemotherapy. Clinical studies have shown that aHSCT is able to completely halt disease activity in the majority of patients with aggressive RRMS. Research on the mechanisms of action supports that aHSCT indeed leads to renewal of a healthy immune system. Below we will summarize important aspects of aHSCT and mention the currently best-examined regimen.

Statistics

Citations

14 citations in Web of Science®
20 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

60 downloads since deposited on 06 Jan 2014
16 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, not refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2013
Deposited On:06 Jan 2014 13:06
Last Modified:05 Apr 2016 17:15
Publisher:Springer Healthcare
ISSN:1092-8480
Additional Information:The original publication is available at link.springer.com
Publisher DOI:https://doi.org/10.1007/s11940-013-0234-9
PubMed ID:23637027

Download

Preview Icon on Download
Preview
Content: Accepted Version
Filetype: PDF
Size: 672kB
View at publisher

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations